Survey & Data Collection Tool Development

The contract entails the design and development of blank questionnaires, surveys, and data collection instruments specifically tailored for use in DHT-enabled clinical studies, ensuring full compliance with FDA and NIH regulatory guidelines. The work must produce instruments that are scientifically sound, user-friendly, and capable of accurately capturing clinical data through digital health technologies, with attention to data integrity, patient privacy, and interoperability standards. All deliverables will be rigorously validated to meet federal requirements for clinical research and must support seamless integration into existing DHT ecosystems used in regulated studies. This is a subcontract under the NAICS code 541910, issued by the Food and Drug Administration within the Department of Health and Human Services, with a posted date of July 20, 2026, and a response deadline of August 20, 2026. The nature of the work requires specialized expertise in clinical research methodology, digital health tools, and regulatory compliance. The place of performance is not specified, indicating flexibility in location, and the solicitation is open to qualified subcontractors who can demonstrate experience in developing compliant data collection tools for federally sponsored clinical trials. There is no set-aside designation, meaning the opportunity is open to all eligible entities.